| Biology of breast cancer bone metastasis M Akhtari, J Mansuri, KA Newman, TM Guise, P Seth Cancer biology & therapy 7 (1), 3-9, 2008 | 243 | 2008 |
| Chronic myelogenous leukemia. S O'Brien S, Abboud CN, Akhtari M, Altman J, Berman J Natl Compr Canc Netw 10 (1), 64-110, 2012 | 186* | 2012 |
| Association of convalescent plasma therapy with survival in patients with hematologic cancers and COVID-19 MA Thompson, JP Henderson, PK Shah, SM Rubinstein, MJ Joyner, ... JAMA oncology 7 (8), 1167-1175, 2021 | 169 | 2021 |
| Management of immune cytopenias in patients with systemic lupus erythematosus—old and new K Newman, MB Owlia, I El-Hemaidi, M Akhtari Autoimmunity reviews 12 (7), 784-791, 2013 | 135 | 2013 |
| Fecal microbiota transplantation for fulminant Clostridium difficile infection in an allogeneic stem cell transplant patient K Neemann, DD Eichele, PW Smith, R Bociek, M Akhtari, A Freifeld Transplant Infectious Disease 14 (6), E161-E165, 2012 | 127 | 2012 |
| An overview and update of chronic myeloid leukemia for primary care physicians A Granatowicz, CI Piatek, E Moschiano, I El-Hemaidi, JD Armitage, ... Korean journal of family medicine 36 (5), 197, 2015 | 100 | 2015 |
| Neutropenia in a patient treated with ipilimumab (anti–CTLA-4 antibody) M Akhtari, EK Waller, DL Jaye, DH Lawson, R Ibrahim, NE Papadopoulos, ... Journal of Immunotherapy 32 (3), 322-324, 2009 | 100 | 2009 |
| Bleeding symptoms in 27 Iranian patients with the combined deficiency of factor V and VIII. MPM Peyvandi F, Tuddenham EGD, Akhtari M, Lak M British Journal of Haematology 100 (4), 773-776, 1998 | 99* | 1998 |
| Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation JM Li, CR Giver, Y Lu, MS Hossain, M Akhtari, EK Waller Immunotherapy 1 (4), 599-621, 2009 | 96 | 2009 |
| Autoimmune neutropenia in adults M Akhtari, B Curtis, EK Waller Autoimmunity reviews 9 (1), 62-66, 2009 | 93 | 2009 |
| Targeting TGF beta signaling for cancer therapy S Iyer, ZG Wang, M Akhtari, W Zhao, P Seth Cancer biology & therapy 4 (3), 261-266, 2005 | 86 | 2005 |
| Chronic myelogenous leukemia, version 1.2014 S O’Brien, JP Radich, CN Abboud, M Akhtari, JK Altman, E Berman, ... Journal of the National Comprehensive Cancer Network 11 (11), 1327-1340, 2013 | 85 | 2013 |
| Chronic myelogenous leukemia, version 1.2015 S O’Brien, JP Radich, CN Abboud, M Akhtari, JK Altman, E Berman, ... Journal of the National Comprehensive Cancer Network 12 (11), 1590-1610, 2014 | 72 | 2014 |
| Felty’s syndrome, insights and updates MB Owlia, K Newman, M Akhtari The open rheumatology journal 8, 129, 2014 | 62 | 2014 |
| Clinical use of blinatumomab for B-cell acute lymphoblastic leukemia in adults KJ Lee, V Chow, A Weissman, S Tulpule, I Aldoss, M Akhtari Therapeutics and clinical risk management, 1301-1310, 2016 | 57 | 2016 |
| Racial disparities in COVID-19 outcomes among black and white patients with cancer J Fu, SA Reid, B French, C Hennessy, C Hwang, NT Gatson, N Duma, ... JAMA network open 5 (3), e224304-e224304, 2022 | 46 | 2022 |
| Hematologic toxicities associated with intravenous immunoglobulin therapy A Baxley, M Akhtari International immunopharmacology 11 (11), 1663-1667, 2011 | 46 | 2011 |
| The locus for combined factor V – factor VIII deficiency (F5F8D) maps to 18q21, between D18s849 and D18s1103. JLB M Neerman-Arbez, M Akhtari, SE Antonarakis Am J Hum Genet 61 (11), 143-150., 1997 | 46 | 1997 |
| Monitoring for chemotherapy-related cardiotoxicity in the form of left ventricular systolic dysfunction: a review of current recommendations JR Stone, R Kanneganti, M Abbasi, M Akhtari JCO Oncology Practice 17 (5), 228-236, 2021 | 45 | 2021 |
| Management of autoimmune neutropenia in Felty's syndrome and systemic lupus erythematosus KA Newman, M Akhtari Autoimmunity reviews 10 (7), 432-437, 2011 | 42 | 2011 |
Edmund K WallerEmory UniversityVerified email at emory.edu
